Online inquiry

IVTScrip™ mRNA-Human ATP11B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26977MR)

This product GTTS-WK26977MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ATP11B protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_014616.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23200
UniProt ID Q9Y2G3
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATP11B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26977MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK11621MR IVTScrip™ mRNA-Human ADCY5, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADCY5
GTTS-WK24866MR IVTScrip™ mRNA-Human ATL1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ATL1
GTTS-WK25506MR IVTScrip™ mRNA-Human APEX1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APEX1
GTTS-WK28686MR IVTScrip™ mRNA-Human ARSJ, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARSJ
GTTS-WK12610MR IVTScrip™ mRNA-Human A4GALT, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA A4GALT
GTTS-WK13081MR IVTScrip™ mRNA-Human ACY3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACY3
GTTS-WK13001MR IVTScrip™ mRNA-Human ACAA1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACAA1
GTTS-WK25223MR IVTScrip™ mRNA-Human APOBEC3G, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA APOBEC3G
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →